Rebecsinib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Rebecsinib, covering 2026-01-27 to 2026-01-27. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Rebecsinib for Patients With Relapsed/Refractory Secondary Acute Myeloid Leukemia or High Risk Myelofibrosis [Phase 1]